05.02.2004
Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study
I. Goldstein, J.M. Young, J. Fischer, K. Bangerter, T. Segerson, T. Taylor, the Vardenafil Diabetes Study Group
Diabetes Care, 2003; 26: 777-783